SCHEMBL6283879

SCHEMBL6283879

C=CC(=O)CCCCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
ABCC4 O15439 1/20 0.56
MAPT P10636 1/20 0.56
TSHR P16473 4/20 0.55
NFKB1 P19838 2/20 0.55
PMP22 Q01453 1/20 0.55
SLC22A6 Q4U2R8 2/20 0.50
GPR84 Q9NQS5 4/20 0.46
FFAR1 O14842 2/20 0.46
FFAR4 Q5NUL3 2/20 0.46
AKR1B1 P15121 1/20 0.46
CYP2D6 P10635 1/20 0.46
FOLH1 Q04609 1/20 0.46
PPARG P37231 5/20 0.44
PPARD Q03181 5/20 0.44
PPARA Q07869 5/20 0.44
HDAC11 Q96DB2 4/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3134798 0.97 TSHR (0.60) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL10343501 0.97 TSHR (0.60) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL12444566 0.97 TSHR (0.60) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL27823673 0.97 TSHR (0.60) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL8032580 0.95 SLC22A6 (0.58) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL6557587 0.89 ALDH1A1 (0.50) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL7824214 0.87 PPARG (0.68) LMNAMAPTTSHRSLC22A6GPR84
SCHEMBL23565658 0.86 ACE (0.48) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL22492168 0.86 TSHR (0.48) LMNAABCC4MAPTTSHRNFKB1
SCHEMBL2691938 0.86 TSHR (0.48) LMNAABCC4MAPTTSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217960-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K UNIVERSITÄT BASEL (CH) 2024-07-04 US disclosed
US-20240217960-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K UNIVERSITÄT BASEL (CH) 2024-07-04 US disclosed
US-20240217960-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K UNIVERSITÄT BASEL (CH) 2024-07-04 US disclosed
CN-118202014-A Adhesive tape 积水化学工业株式会社 2024-06-14 CN disclosed
EP-4320110-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K Universität Basel (CH) 2024-02-14 EP disclosed
CN-116547360-A Adhesive tape 积水化学工业株式会社 2023-08-04 CN disclosed
CN-116529336-A Adhesive tape and adhesive composition 积水化学工业株式会社 2023-08-01 CN disclosed
WO-2022214701-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K UNIVERSITÄT BASEL (CH) 2022-10-13 WO disclosed
US-20110071036-A1 ISOELECTRIC FOCUSING BIOCHIP KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2011-03-24 US disclosed
US-6864287-B1 Derivatives of dicarboxylic acid having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2005-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217960-A1 TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K PIK3R5, PIK3R1, PIK3R2 LMNA 4234/4885ABCC4 213/4885MAPT 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.